Cerebras Systems (CBRS) is receiving its first wave of Wall Street analyst coverage, and the verdict is overwhelmingly bullish. The AI chipmaker, which completed one of the most anticipated IPOs of the year, surged nearly 20% Monday after the expiration of the post-IPO quiet period allowed analysts to formally publish their views on the stock.
The enthusiastic reception comes after a volatile first few weeks as a public company. Cerebras priced its IPO at $185 per share in May but immediately became one of the market's hottest AI trades, opening near $350 and briefly touching $386 during its first day of trading. That enthusiasm quickly faded as investors locked in profits and broader concerns emerged around AI infrastructure spending, sending shares down nearly 50% from their highs. The stock ultimately bottomed near $196 on Friday before Monday's analyst-driven rebound.
What makes the analyst response notable is not simply the number of firms initiating coverage, but the consistency of their bullish outlooks.
Among the major firms launching coverage, Citi initiated with a Buy rating and a $340 price target, the highest on Wall Street. Barclays started with an Overweight rating and a $280 target, while Morgan Stanley assigned an Overweight rating and a $250 target. Mizuho, UBS, Rosenblatt, Needham, TD Cowen, and Wedbush all launched coverage with positive ratings and price targets ranging from $270 to $300.
The average target price sits close to $290, implying substantial upside from Friday's closing price and suggesting Wall Street believes the recent correction was overdone.
The core bullish thesis centers around one concept: inference.
For much of the AI boom, investors focused on training large language models. Increasingly, however, analysts believe the next phase of AI spending will revolve around inference, the process of generating responses once models have already been trained. This is where Cerebras believes its technology holds a unique advantage.
Wedbush described Cerebras as the only company that has successfully commercialized wafer-scale AI silicon, arguing that the company's third-generation Wafer Scale Engine (WSE-3) is specifically designed for the high-value inference market where speed matters more than raw computing power. The firm sees the industry shifting from training toward inference and believes Cerebras is uniquely positioned to benefit from that transition.
Mizuho made a similar argument, calling Cerebras a leader in what it believes could become the fastest-growing segment of the AI ecosystem. The firm projects the "fast inference" market could grow at a staggering 291% compound annual growth rate through 2030 and ultimately reach roughly $550 billion in annual spending.
Several analysts highlighted Cerebras' technical differentiation. Unlike traditional AI processors, the company's Wafer Scale Engine integrates massive amounts of on-chip SRAM memory and bandwidth, allowing it to process AI workloads with significantly lower latency. Needham described the technology as possessing orders of magnitude more SRAM capacity and memory bandwidth than competing AI processors.
Citi went even further, arguing that Cerebras possesses a two-to-three-times token generation speed advantage over competing solutions. The firm believes the company could eventually capture 40% to 50% of the fast inference market, which it estimates could represent a $130 billion opportunity by 2030.
Beyond the technology story, analysts were particularly focused on two strategic partnerships.
The first is Cerebras' reported $20 billion-plus agreement with OpenAI. The deal includes plans to deploy approximately 750 megawatts of Cerebras-powered compute capacity through 2028, with options for additional expansion. Nearly every analyst cited the OpenAI relationship as a major validation of the company's technology and business model.
The second catalyst is Amazon Web Services. Several firms noted that AWS has already announced plans to integrate Cerebras systems into its cloud infrastructure offerings. Analysts view this relationship as potentially transformative because it could expose Cerebras technology to a much broader enterprise customer base.
Needham specifically noted that meaningful AWS deployments could create substantial upside to current revenue estimates.
Revenue growth projections are equally aggressive. Rosenblatt highlighted annual revenue growth from approximately $25 million in 2022 to an estimated $510 million in 2025. Mizuho projects a 122% compound annual growth rate between 2025 and 2029, while analysts broadly expect the company to achieve multi-billion-dollar annual revenue within several years.
Of course, not everything is positive.
The biggest concern remains valuation. Even after falling nearly 50% from its post-IPO peak, the stock still trades at aggressive multiples based on future revenue estimates rather than current earnings. Rosenblatt's $300 price target is based on 14 times projected 2028 revenue, while Mizuho's valuation framework utilizes a 15 times forward sales multiple. Those assumptions leave little room for execution missteps.
There is also customer concentration risk. Much of the current bullish thesis revolves around OpenAI and AWS. If either relationship fails to scale as expected, growth projections could require significant revision.
Competition presents another challenge. While analysts praise Cerebras' technological differentiation, the company is still competing against industry giants such as Nvidia Corporation (NVDA), Advanced Micro Devices (AMD), and a growing list of custom silicon providers backed by hyperscale cloud companies.
From a technical perspective, the stock remains in price discovery mode given its recent IPO. However, traders are already identifying several important levels. Shares experienced notable breakdowns below $270 and later below $240 during the post-IPO correction. As a result, those levels now represent important resistance zones that many traders will monitor as the stock attempts to rebuild momentum.
Ultimately, Wall Street's message is clear. Analysts view Cerebras as one of the most differentiated AI infrastructure companies to reach the public markets in recent years. The combination of proprietary wafer-scale technology, massive AI infrastructure spending trends, and high-profile partnerships with OpenAI and Amazon has created a compelling growth narrative. The question investors now face is not whether Cerebras has a large opportunity ahead of it, but whether that opportunity is already reflected in the stock's valuation after one of the most volatile IPO debuts in recent memory.

